Moolec Science SA (MLEC)
1.170
-0.03
(-2.11%)
USD |
NASDAQ |
May 31, 16:00
1.18
+0.01
(+0.85%)
Pre-Market: 20:00
Moolec Science Cash from Investing (Quarterly): -0.1281M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.1281M |
September 30, 2023 | 0.1746M |
June 30, 2023 | -2.188M |
Date | Value |
---|---|
March 31, 2023 | -0.0823M |
December 31, 2022 | -0.0664M |
September 30, 2022 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.188M
Minimum
Jun 2023
0.1746M
Maximum
Sep 2023
-0.3817M
Average
-0.0744M
Median
Cash from Investing (Quarterly) Benchmarks
Alvotech | -3.48M |
Procaps Group SA | -7.469M |
Sunshine Biopharma Inc | -0.6687M |
Bio-Path Holdings Inc | -- |
Palisade Bio Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.904M |
Cash from Financing (Quarterly) | 4.82M |
Free Cash Flow | -12.79M |
Free Cash Flow Per Share (Quarterly) | -0.1031 |
Free Cash Flow to Equity (Quarterly) | -9.350M |
Free Cash Flow to Firm (Quarterly) | -3.697M |
Free Cash Flow Yield | -28.90% |